Physician profile
Jose Centurion
NPI 1275299083
$1,249.17
in general payments reported to CMS, 2019-2025
13 companies · $119 in 2025
The $119 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $165 · 2023: $210 · 2024: $756 · 2025: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,067 · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,067.21 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $218.27 | 2024 | |
| Impulse Dynamics (USA) INC. | $151.72 | 2024 | Optimizer |
| Lexicon Pharmaceuticals, INC. | $143.02 | 2023-2024 | Inpefa |
| Aimmune Therapeutics, INC. | $125.00 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $121.84 | 2024 | Wainua |
| Mylan Specialty L.P. | $108.80 | 2023 | Yupelri |
| Surmodics, INC. | $102.87 | 2022 | |
| Baxter Healthcare | $77.91 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Insmed, INC. | $61.96 | 2025 | Brinsupri, Arikayce |
| Amarin Pharma, INC. | $59.29 | 2022-2023 | |
| E.R. Squibb & Sons, L.L.C. | $45.42 | 2022-2023 | Eliquis |
| Janssen Pharmaceuticals, INC | $17.45 | 2024 | Xarelto |
| Pulmonx Corporation | $15.62 | 2023 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Centurion listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.